SCHEMBL81943

SCHEMBL81943

Pc1cccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4337737 0.97
Bromide SCHEMBL14778365 0.97
SCHEMBL28860574 0.88 HPGDS (0.33)
SCHEMBL30570951 0.65 FBP1 (0.39)
SCHEMBL16291133 0.65 L3MBTL1 (0.57)
SCHEMBL3545 0.65 L3MBTL1 (0.57)
SCHEMBL2643305 0.63
Ammonia Solution, Strong SCHEMBL34467257 0.62 L3MBTL1 (0.55)
Benzene SCHEMBL28420098 0.62 L3MBTL1 (0.55)
Fluoride SCHEMBL491501 0.62 L3MBTL1 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 309 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240016933-A1 Methods of Anchoring or Reconstituting Active Molecules on Metabolically Labeled Cells MASSACHUSETTS GEN HOSPITAL (US) 2024-01-18 US claimed
US-20240002908-A1 METHODS OF DETERMINING SURFACE GLYCAN DENSITY MASSACHUSETTS GEN HOSPITAL (US) 2024-01-04 US claimed
US-20230414764-A1 Template Assembly by Proximity-Enhanced Reactivity via Metabolic Labeling MASSACHUSETTS GEN HOSPITAL (US) 2023-12-28 US claimed
US-20230406839-A1 Bifunctional Compounds And Methods Of Using The Same THE GENERAL HOSPITAL CORPORATION 2023-12-21 US claimed
EP-4240421-A1 BIFUNCTIONAL COMPOUNDS AND METHODS OF USING THE SAME The General Hospital Corporation (US) 2023-09-13 EP claimed
CN-112387280-B Method for preparing isopentenal by oxidizing enol 山东新和成药业有限公司 2022-10-21 CN claimed
WO-2022099058-A1 METHODS OF DETERMINING SURFACE GLYCAN DENSITY THE GENERAL HOSPITAL CORPORATION (US) 2022-05-12 WO claimed
WO-2022099043-A1 BIFUNCTIONAL COMPOUNDS AND METHODS OF USING THE SAME THE GENERAL HOSPITAL CORPORATION (US) 2022-05-12 WO claimed
WO-2022099055-A1 TEMPLATE ASSEMBLY BY PROXIMITY-ENHANCED REACTIVITY VIA METABOLIC LABELING THE GENERAL HOSPITAL CORPORATION (US) 2022-05-12 WO claimed
WO-2022099040-A1 METHODS OF ANCHORING OR RECONSTITUTING ACTIVE MOLECULES ON METABOLICALLY LABELED CELLS THE GENERAL HOSPITAL CORPORATION (US) 2022-05-12 WO claimed
US-20040030105-A1 Chemical synthesis of reagents for peptide coupling NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-02-12 US claimed
JP-2004501103-A 2004-01-15 JP claimed
WO-2003104243-A1 CHEMICAL SYNTHESIS OF REAGENTS FOR PEPTIDE COUPLING WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2003-12-18 WO claimed
EP-0882059-B1 SOLID PHASE SYNTHESIS OF OLIGONUCLEOTIDE N3-'P5'- PHOSPHORAMIDATES LYNX THERAPEUTICS INC (US) 2002-02-06 EP claimed
WO-2001087920-A2 LIGATION METHOD AND REAGENTS TO FORM AN AMIDE BOND WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2001-11-22 WO claimed
EP-0165289-B1 NOVEL DERIVATIVES OF GUANINE Medivir Aktiebolag (SE) 1989-04-05 EP claimed
EP-0103552-B1 NOVEL DERIVATIVES OF GUANINE Astra Läkemedel Aktiebolag (SE) 1986-05-07 EP claimed
EP-0103551-B1 NOVEL DERIVATIVES OF GUANINE Astra Läkemedel Aktiebolag (SE) 1986-02-26 EP claimed
EP-0009566-B1 2-CYCLOALKYL-PYRIMIDIN(5)YL-(THIONO)(THIOL)-PHOSPHORIC (PHOSPHONIC)-ACID ESTER OR -ESTERAMIDES, PROCESS FOR THEIR PREPARATION AND USE AS INSECTICIDES, ACARICIDES AND NEMATICIDES BAYER AG (DE) 1981-09-09 EP claimed
EP-0009566-A2 2-Cycloalkyl-pyrimidin(5)yl-(thiono)(thiol)-phosphoric (phosphonic)-acid ester or -esteramides, process for their preparation and use as insecticides, acaricides and nematicides BAYER AG (DE) 1980-04-16 EP claimed